Selected article for: "affected population MMR immunity status compare and MMR immunity status compare"
Author: Robin Franklin; Adam Young; Bjoern Neumann; Rocio Fernandez; Alexis Joannides; Amir Reyahi; Yorgo Modis
Title: Homologous protein domains in SARS-CoV-2 and measles, mumps and rubella viruses: preliminary evidence that MMR vaccine might provide protection against COVID-19
  • Document date: 2020_4_10
    • ID: nd5r4yt4_24
    Snippet: The copyright holder for this preprint . https://doi.org/10.1101/2020.04.10.20053207 doi: medRxiv preprint 3 countries studied. Nevertheless, older populations and males are both more likely to die from Covid-19, and less likely to be seropositive for rubella specific immunity, based on historical vaccination programmes of all three countries considered in this study. In order to conclude whether MMR vaccination can improve the outcomes from Covi.....
    Document: The copyright holder for this preprint . https://doi.org/10.1101/2020.04.10.20053207 doi: medRxiv preprint 3 countries studied. Nevertheless, older populations and males are both more likely to die from Covid-19, and less likely to be seropositive for rubella specific immunity, based on historical vaccination programmes of all three countries considered in this study. In order to conclude whether MMR vaccination can improve the outcomes from Covid-19 infection, a study using individual based data to compare MMR immunity status in the affected population is warranted.

    Search related documents:
    Co phrase search for related documents
    • affected population and infection outcome: 1, 2
    • affected population and MMR immunity status: 1
    • affected population and MMR immunity status compare: 1
    • affected population and MMR vaccination: 1
    • affected population and old population: 1, 2, 3, 4, 5, 6, 7
    • affected population and rubella specific immunity: 1
    • affected population and specific immunity: 1
    • affected population and vaccination programme: 1
    • affected population MMR immunity status compare and immunity status: 1
    • affected population MMR immunity status compare and infection outcome: 1
    • affected population MMR immunity status compare and MMR immunity status: 1
    • affected population MMR immunity status compare and MMR immunity status compare: 1
    • affected population MMR immunity status compare and MMR vaccination: 1
    • affected population MMR immunity status compare and rubella specific immunity: 1
    • affected population MMR immunity status compare and specific immunity: 1
    • immunity status and infection outcome: 1, 2
    • immunity status and MMR immunity status: 1
    • immunity status and MMR immunity status compare: 1
    • immunity status and MMR vaccination: 1